Current study status of radiotherapy modality on early stage nasal NK/T cell lymphoma
10.3760/cma.j.issn.1009-9921.2012.10.021
- VernacularTitle:早期鼻腔NK/T细胞淋巴瘤放疗模式的研究现状
- Author:
Baolin HAN
- Publication Type:Journal Article
- Keywords:
Lymphoma,Non-Hodgkin;
Nasal Cavity;
Radiation target;
Radiation dose;
Preventive neck radiation
- From:
Journal of Leukemia & Lymphoma
2012;21(10):636-637
- CountryChina
- Language:Chinese
-
Abstract:
Nasal NK/T cell lymphoma is a rare and distinct type of extranodal Non-Hodgkin' s lymphoma. Current study has proved that Radiotherapy is the most effective treatment method in the early stage nasal NK/T cell lymphoma, but there is no universal standard for concrete radiotherapy modality, such as the radiation target, the radiation dose and preventive neck radiation. Most studies have proved that radiotherapy of extended field and higher dose achieved good effect in early stage nasal NK/T cell lymphoma.And the studies also do not suggested preventive neck radiation in local stage patients, but it need further study in the extensive stage patients.
